Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proshares Trust (ZBIO) Current Leases (2023 - 2025)

Historic Current Leases for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $618000.0.

  • Zenas BioPharma's Current Leases rose 6093.75% to $618000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $618000.0, marking a year-over-year increase of 6093.75%. This contributed to the annual value of $785000.0 for FY2024, which is 4118.71% up from last year.
  • According to the latest figures from Q3 2025, Zenas BioPharma's Current Leases is $618000.0, which was up 6093.75% from $793000.0 recorded in Q2 2025.
  • Zenas BioPharma's 5-year Current Leases high stood at $908000.0 for Q1 2025, and its period low was $384000.0 during Q3 2024.
  • Over the past 3 years, Zenas BioPharma's median Current Leases value was $701500.0 (recorded in 2024), while the average stood at $674000.0.
  • Per our database at Business Quant, Zenas BioPharma's Current Leases soared by 4118.71% in 2024 and then soared by 6093.75% in 2025.
  • Quarter analysis of 3 years shows Zenas BioPharma's Current Leases stood at $556000.0 in 2023, then soared by 41.19% to $785000.0 in 2024, then dropped by 21.27% to $618000.0 in 2025.
  • Its Current Leases stands at $618000.0 for Q3 2025, versus $793000.0 for Q2 2025 and $908000.0 for Q1 2025.